CASE REPORT A 57yearold African–American male presented to our hospital with a one week history of progressive right lower extremity pain and swelling, associated with fevers, chills and night sweats. Review of systems revealed a one week history of dry cough and rightsided pleuritic chest pain. He received an orthotopic liver transplant four months earlier at our institution for end stage liver disease and cirrhosis secondary to Hepatitis C. After transplantation, his maintenance immunosuppressive regimen included tacrolimus (2 mg every morning, 1 mg every evening), and mycophenolate mofetil (1000 mg twice daily). On admission, he was afebrile. His right lower extremity was exquisitely tender to palpation; erythema, warmth and 2+ pitting edema were also noted (Figure 1). No nodules, ulcers, pustules or papules were noted on the lower extremities. His whitebloodcell count was 9900 cells per uL, with 85% neutrophils and 2% bands. Radiography of the right lower extremity did not reveal a fracture and an ultrasound did not demonstrate a deep vein thrombosis. Chest Xray revealed a new nodular density in the right midlung. Computed tomography (CT) scan of the chest was obtained and revealed multifocal pneumonia (Figure 2). Vancomycin and cefepime were initiated empirically for suspected bacterial cellulitis and pneumonia. Despite 48 hours of antibiotic therapy, the patient’s symptoms failed to improve. Serum cryptococcal antigen was obtained and the titer was positive at 1:10. A skin biopsy was performed and revealed necrotizing granulomas, with the GMS stain revealing yeasts. Bronchoscopy and transbronchial biopsy also showed yeasts (Figure 3). C. neoformans was subsequently isolated from his bronchoalveolar lavage. Lumbar puncture was performed and the CSF was unremarkable. The patient received liposomal amphotericin B at 3 mg/kg per day for two weeks, during which time tacrolimus dosing was decreased by 50% and mycophenolate mofetil was discontinued. Improvement in cellulitis and pulmonary infiltrates was noted and he transitioned to oral fluconazole. His tacrolimus dosing remained reduced for the first three months of therapy as an outpatient. The patient completed a 12month course of fluconazole and has not demonstrated relapse to date. DISCUSSION In 2010, the TransplantAssociated Infection Surveillance Network identified Cryptococcus as the 3rd leading cause of invasive fungal infections in solid organ transplant recipients, with an incidence of 8% and a oneyear mortality rate of 27% [1]. Although cryptococcal disease has a median onset of greater than one year posttransplantation, this varies with the type of organ transplanted; in the case of liver transplant recipients it is 8.8 months [1, 2]. While the majority of cryptococcal disease among solid organ transplant recipients is disseminated or involves the central nervous system, it may also present with skin, soft tissue or osteoarticular infection [3]. Rates of skin and soft tissue infection have been reported in the range of 13–18% [2, 4]. A variety of manifestations have been reported: nodules, maculopapular lesions, ulcers, pustules, abscesses and cellulitis, with the most common site being the lower CLINICAL IMAGES OPEN ACCESS